Health Pilot

To what extent does the project represent an ambitious innovation that is supported by relevant and high-quality R&D activities?

• To what extent does the innovation represent something novel?
• To what extent will the innovation help to resolve a challenge and/or meet a recognised need in the health services?
• To what extent is the innovation targeted towards new market opportunities for the companies that are partners in the project?

• To what extent does the project build on relevant and updated knowledge?
• To what extent does the project employ relevant and recognised R&D methods?
• To what extent are the R&D activities essential for the success of the innovation?

To what extent do the project plan and the project group provide a good basis for implementing the R&D activities and utilising the results?

• To what extent does the R&D project plan incorporate appropriate and effective objectives, work packages, milestones, resources and relevant risk assessments?
• To what extent are the plans for user participation relevant and appropriate?

• To what extent does the project group have the competence and expertise necessary to ensure efficient implementation of the R&D project and with sufficient capacity?
• To what extent is the project strategically aligned with the partners and is the distribution of the budget, roles and responsibilities clearly defined and relevant?
• To what extent does the project manager have relevant expertise and experience to lead an R&D project targeted towards innovation and value creation through public-private collaboration?

• To what extent does the project group have the competence and capacity necessary to ensure utilisation of the R&D results and realisation of the benefits?

To what extent does the project pave the way for benefits and value creation in public sector bodies and the Norwegian business sector, and form the basis for other positive impacts in society? To what extent are the potential impacts of the project clearly formulated and plausible?

• To what extent will the project entail a potential for sustainable value creation in the Norwegian business sector with significant economic benefits for companies?
• To what extent will the project form the basis for benefits and value creation in the health sector in the form of more sustainable health and care services?
• To what extent can the project generate other positive external effects for patients, inhabitants and society or in the form of knowledge dissemination?

• To what extent does the plan for implementation of the R&D results and realisation of benefits give reason to indicate that the project can achieve the impacts described? Is the plan relevant and appropriate, for example in relation to
- needs and plans for adapting the organisation, systems and/or work processes;
- needs and plans for investments and allocation of resources;
- management of IPR and regulatory approvals;
- development of business models and/or commercialisation plans incl. partnerships;
- risk assessments in relation to e.g. implementation and/or market access;
- dissemination and communication.

To what extent does the project comply with the requirements and guidelines set out in the call?

• To what extent does the application meet the requirements set out in the call and expectations with regard to the Project Owner and partnership constellations?
• To what extent does the application meet the expectations and characteristics of the projects set out in the call?
• To what extent is the project in keeping with thematic priorities set out in the call?